1 / 9

Parkinson’s Disease Market

Parkinson's disease is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. Parkinson's symptoms usually begin gradually and get worse over time. As the disease progresses, people may have difficulty in walking and talking. They may further experience mental &behavioral changes, sleep problems, depression, memory difficulties, and fatigue. Parkinsonu2019s disease can be prevalent in both men and women. However, the disease affects about 50% more men than women. One clear risk factor for Parkinson's is age.

Pranay6
Download Presentation

Parkinson’s Disease Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. GET PDF Parkinson’s Disease Market GLOBAL OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST 2023-2032 KNOW MORE

  2. CURRENT AND FUTURE MARKET SCENARIO 1. Rising Prevalence: The current market for Parkinson's disease is characterized by a growing prevalence of the condition, particularly in aging populations. This trend is expected to continue in the future, driving the demand for innovative treatments and therapies. 2. Advancements in Treatment: The future of the Parkinson's disease market is marked by ongoing research and development efforts to discover new treatment modalities, including gene therapies and disease-modifying drugs. These advancements hold the promise of improving the quality of life for patients and may potentially slow the progression of the disease.

  3. FACTORS CONTRIBUTING TO MARKET GROWTH 1. Aging Population: The global increase in the aging population is a significant factor contributing to the growth of the Parkinson's disease market. Parkinson's disease is more prevalent in older individuals, and as the elderly population grows, so does the number of people affected by the disease. 2. Advances in Research and Treatment: Ongoing research and the development of innovative treatments for Parkinson's disease are driving market growth. New therapies, medications, and deep brain stimulation techniques offer improved management of the disease's symptoms, enhancing the quality of life for patients and increasing market demand for these solutions. For more details: Click Here

  4. MARKET SEGMENTATION By Product By Route of Administration By End Users •North America •Europe •Asia-Pacific •LAMEA •Monoamine Oxidase Inhibitors (MAOIs) •Catechol-O-methyl transferase (COMT) Inhibitors •Dopamine Agonists •Peripheral Decarboxylase Inhibitors •Levodopa combination therapy •Oral •subcutaneous •Transdermal •Intestinal Infusion •Others

  5. DOMINATING SEGMENTS Deep Brain Stimulation (DBS) Segment Medications Segment Deep Brain Stimulation, a surgical intervention that involves implanting electrodes in the brain to regulate abnormal neural activity, is a rapidly growing and dominant segment in the Parkinson's Disease market, particularly for patients with advanced stages of the disease. Medications for managing the symptoms of Parkinson's disease, including dopamine agonists, levodopa-based therapies, and other pharmaceuticals, constitute a dominating segment in the market. These drugs are often the first-line treatment for Parkinson's disease.

  6. GEOGRAPHICAL OVERVIEW 1. North America Dominance: North America, particularly the United States and Canada, holds a significant share in the global Parkinson's disease market. The region's advanced healthcare infrastructure, robust research and development initiatives, and a large patient population contribute to its leadership in the market. 2. Emerging Markets in Asia-Pacific: The Asia-Pacific region, including countries like China and India, is experiencing a surge in Parkinson's disease cases due to an aging population and changing lifestyles. As a result, pharmaceutical companies are increasingly targeting these markets, making the Asia-Pacific a region of growing importance in the Parkinson's disease market.

  7. LEADING MARKET PLAYERS Acadia Pharmaceuticals Boehringer Ingelheim GmbH AbbVie Inc Abbvie Inc Sunovion Pharmaceuticals Schwarz Pharma Novartis AG F. Hoffmann La Roche Ltd Pharma Two B Ltd Medtronic Plc          

  8. To Know More About Parkinson’s Disease Market- Opportunities and Forecasts, 2023-2032 Read More Purchase Enquiry - Click Here Follow Allied Market Research

  9. ABOUT ALLIED MARKET RESEARCH Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Contact: David Correa 1209 Orange Street, Corporation Trust Center, Wilmington, New Castle, Delaware 19801 USA. USA/Canada (Toll Free): +1-800-792-5285 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-800-792-5285 help@alliedmarketresearch.com

More Related